Events
PurpleStride Supports the Pancreatic Cancer Action Network’s Urgent Mission to Save Lives and
Signant proud to take leadership role at 10th annual summit as key pioneers and thought leaders convene to advance the science and technology of CNS research
MaxCyte, the global cell-based therapies and life sciences company, announces two presentations at the 5th Annual Cell & Gene Therapy Congress taking place 29-30 October in London, UK, which showcase the Company’s cell therapy technology.
Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that advanced radiation therapy delivered within PetCure-developed treatment protocols is leading to better survival outcomes than other treatment options for at least nine specific tumor types.
Low-cost, flexible and dependable automation possibilities open up for any research group
MorphoSys AG will publish its first nine months’ 2019 results on October 29, 2019 at 10:00pm CET
The theme of the 2019 World Congress of Neurology (WCN 2019), Accelerating the Pace of Change, emphasizes the global effort to further neurological healthcare, and serves as a springboard to advance the field of neurology around the globe.
APEIRON Biologics AG announced that it will present preclinical data for its clinical stage project APN401 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 26-30 October 2019 in Boston, MA, USA.
Not-for-profit organization i2 Learning administered professional development workshops in Attleboro, Everett, Peabody, Methuen and Westfield, made possible in part by $50,000 in MLSC funding
Cytel Inc. has announced that the Complex Innovative Trial Design Symposium and East® Training will take place November 6–7 at Alexion’s headquarters in Boston, Massachusetts.
PRESS RELEASES